Page last updated: 2024-09-04

ertiprotafib and Obesity

ertiprotafib has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bombrun, A; Hooft van Huijsduijnen, R; Sauer, WH; Swinnen, D1
Bhattarai, BR; Chang, KJ; Cho, H; Lee, KH; Shrestha, S1

Reviews

1 review(s) available for ertiprotafib and Obesity

ArticleYear
Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs.
    Journal of medicinal chemistry, 2004, Aug-12, Volume: 47, Issue:17

    Topics: Animals; Diabetes Mellitus, Type 2; Glucose; Humans; Hypoglycemic Agents; Obesity; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases

2004

Other Studies

1 other study(ies) available for ertiprotafib and Obesity

ArticleYear
Methylenedisalicylic acid derivatives: new PTP1B inhibitors that confer resistance to diet-induced obesity.
    Bioorganic & medicinal chemistry letters, 2007, May-15, Volume: 17, Issue:10

    Topics: Adipocytes; Animals; Anti-Obesity Agents; Diet; Disease Models, Animal; Mice; Mice, Inbred C57BL; Obesity; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Salicylates; Weight Gain

2007